NanoMedTrix is a biotechnology company that develops and manufactures innovative nanoparticles for use in a variety of medical applications. Our nanoparticles are uniquely visible in echo, MRI, CT and by fluorescence, making them ideal for use in studies of carriers for therapeutic payload to a site of interest. NanoMedtrix has reached scaling-up levels for commercial applications, including manufacturing strategies for purities, excluding toxic materials, and ready-to-GMP preparations. The loading capacity can be adjusted to accommodate the molecular size of the cargo and the most suitable dosage requirement. In addition, the synthesis incorporates co-crystallization with agents known to have contrast signals in MRI, CT, and Ultrasound. This unique feature allows for real-time/non-invasive monitoring of therapeutic success. Imaging and particle-mediated treatment have been optimized in wide orthotopic and xenograft models. Targeting as surface modification provides yet another level of specificity to the drugs delivered. Our products have been tested for tumoricidal effects with various drug classes such as taxanes, antineoplastic antibiotics, antimetabolite agents, and anti-angiogenic. Multi-drug treatment and sequential regiment cycles and treatment modalities (oral, intravesicular, per-rectum, intravascular) have been consistently given high levels of cancer reduction while showing a fast clearance.
